{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:10:11Z","timestamp":1759104611725,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC Centre of Research Excellence in Peripheral Arterial Disease","doi-asserted-by":"publisher","award":["1000967"],"award-info":[{"award-number":["1000967"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Program Grant","doi-asserted-by":"publisher","award":["546272"],"award-info":[{"award-number":["546272"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Senior Research Fellowship","doi-asserted-by":"publisher","award":["491099"],"award-info":[{"award-number":["491099"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council (ARC) Linkage Project","doi-asserted-by":"publisher","award":["LP077532"],"award-info":[{"award-number":["LP077532"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijcard.2014.04.230","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T16:02:01Z","timestamp":1398700921000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-3522","authenticated-orcid":false,"given":"Zanfina","family":"Ademi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Bohensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.04.230_bb0005","first-page":"e18","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ehj.2004.03.011","article-title":"Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences","volume":"25","author":"Viles-Gonzalez","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/11530670-000000000-00000","article-title":"Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry","volume":"10","author":"Ademi","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijcard.2014.04.230_bb0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCOUTCOMES.109.930735","article-title":"Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States","volume":"3","author":"Mahoney","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/00019053-200321090-00003","article-title":"The comparative medical costs of atherothrombotic disease in European countries","volume":"21","author":"Levy","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.ijcard.2014.04.230_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2011.09.016","article-title":"Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease","volume":"43","author":"Smolderen","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0050","first-page":"297","article-title":"One-year costs associated with cardiovascular disease in Canada: insights from the REduction of Atherothrombosis for Continued Health (REACH) registry","volume":"26","author":"Smolderen","year":"2010","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.04.230_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ahj.2005.02.028","article-title":"The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry","volume":"151","author":"Kauf","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinthera.2010.01.009","article-title":"The economic implications of treating atherothrombotic disease in Australia, from the government perspective","volume":"32","author":"Ademi","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0065","first-page":"e1","article-title":"The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design","volume":"151:786","author":"Ohman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.hlc.2007.07.009","article-title":"Australians at risk: management of cardiovascular risk factors in the REACH Registry","volume":"17","author":"Reid","year":"2008","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1755-5922.2009.00090.x","article-title":"Drug treatment and cost of cardiovascular disease in Australia","volume":"27","author":"Ademi","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3111\/13696998.2011.614304","article-title":"Predictors of government subsidized pharmaceutical use in patients with diabetes or cardiovascular disease in a primary care setting: evidence from a prospective randomized trial","volume":"14","author":"Hirst","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0090","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00125-008-1150-5","article-title":"Lifetime risk and projected population prevalence of diabetes","volume":"51","author":"Magliano","year":"2008","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.ijcard.2014.04.230_bb0095","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/DC12-2501","article-title":"Diabetes prevention and treatment strategies: are we doing enough?","volume":"36","author":"Backholer","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ijcard.2014.04.230_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/1755-5922.12034","article-title":"The impact of Lost Therapeutic Benefit (LTB) in high-risk hypertensive patients: two-year follow-up data from the Australian REACH registry","volume":"31","author":"Ademi","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.ijcard.2014.04.230_bb0105","first-page":"38","article-title":"Cardiac rehabilitation past, present and future: an overview","volume":"2","author":"Mampuya","year":"2012","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ijcard.2014.04.230_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF03405572","article-title":"Protective vascular treatment of patients with peripheral arterial disease: guideline adherence according to year, age and gender","volume":"101","author":"Paquet","year":"2010","journal-title":"Can J Public Health"},{"issue":"2","key":"10.1016\/j.ijcard.2014.04.230_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcard.2014.04.230_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0130","first-page":"150","article-title":"Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications","volume":"181","author":"Norman","year":"2004","journal-title":"MJA"},{"issue":"7","key":"10.1016\/j.ijcard.2014.04.230_bb0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/europace\/eun048","article-title":"Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation","volume":"10","author":"Ringborg","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2014.04.230_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3111\/13696990802063425","article-title":"Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective","volume":"11","author":"Lee","year":"2008","journal-title":"J Med Econ"},{"article-title":"The Economic Costs of Atrial Fibralation in Australia","year":"2010","series-title":"Report, PricewaterhouseCoopers","key":"10.1016\/j.ijcard.2014.04.230_bb0150"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2014.04.230_bb0155","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.thromres.2012.08.277","article-title":"Antithrombotic treatment of atrial fibrillation: new insights","volume":"130","author":"Le Heuzey","year":"2012","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.ijcard.2014.04.230_bb0160","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ijcard.2014.04.230_bb0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacc.2012.03.019","article-title":"Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation","volume":"60","author":"Lip","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:35:08Z","timestamp":1759091708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314009267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0167527314009267"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.230","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}